Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.470
+0.050 (3.52%)
Feb 13, 2026, 4:00 PM EST - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $60.63 million as of February 13, 2026. Its market cap has decreased by -73.01% in one year.
Market Cap
60.63M
Enterprise Value
40.65M
1-Year Change
-73.01%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $60.63M, a decrease of -95.45%. That is a compound annual growth rate of -43.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 60.63M | -33.48% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xtant Medical Holdings | 81.83M |
| MaxCyte | 76.76M |
| InspireMD | 74.15M |
| QT Imaging Holdings | 66.84M |
| Sensus Healthcare | 63.40M |
| Accuray | 62.07M |
| Outset Medical | 61.59M |
| Spectral AI | 47.57M |